Malignant neoplasm of subglottis
ICD-10 C32.2 is a billable code used to indicate a diagnosis of malignant neoplasm of subglottis.
C32.2 refers to malignant neoplasms located in the subglottis, which is the area of the larynx situated below the vocal cords and above the trachea. This type of cancer is relatively rare compared to other laryngeal cancers, but it can significantly impact voice function and airway management. Symptoms may include hoarseness, difficulty breathing, and a persistent cough. Diagnosis typically involves laryngoscopy and biopsy to confirm malignancy. Treatment options may include surgery, radiation therapy, and chemotherapy, depending on the stage of the cancer. Voice preservation is a critical consideration in treatment planning, especially for patients who rely on their voice for professional or personal reasons. Staging of subglottic cancer follows the TNM classification system, assessing tumor size (T), lymph node involvement (N), and distant metastasis (M) to determine the appropriate therapeutic approach and prognosis.
Detailed laryngoscopy findings, biopsy results, and treatment plans.
Patients presenting with hoarseness, difficulty breathing, or abnormal findings on imaging.
Ensure thorough documentation of voice function assessments and treatment outcomes.
Comprehensive staging information, treatment protocols, and follow-up care details.
Patients undergoing chemotherapy or radiation therapy for subglottic cancer.
Document any multidisciplinary approaches to treatment and patient responses.
Used for initial evaluation of suspected laryngeal cancer.
Document findings from the laryngoscopy and any biopsies performed.
Otolaryngologists should ensure thorough documentation of the laryngeal anatomy observed.
Common symptoms include hoarseness, difficulty breathing, a persistent cough, and sometimes pain in the throat or neck.
Diagnosis typically involves a laryngoscopy to visualize the larynx and a biopsy to confirm the presence of malignant cells.
Treatment options may include surgery, radiation therapy, and chemotherapy, with a focus on preserving voice function when possible.
